Supplementary results reveal BBOX1 affects metastatic cancer cell evasion from NK cells, suggesting a role in immunosurveillance.
BBOX1pos and BBOX1neg tumor cells do not differ in tumorigenicity, in vitro proliferation and migration ability.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: